Viral hepatitis: Human genes that limit infection

Treatment response and susceptibility to chronic viral hepatitis C and B may be modified by host genetic factors The majority of genetic variants that confer a significant risk have been localized in genes Involved in immune response However many findings could not be replicated and almost none of the identified risk factors had a noticeable impact on clinical decisions In contrast recent findings in independent large genome wide association studies confirmed genetic variants in the interferon gamma gene locus as strong predictors of outcome with outstanding clinical relevance This review gives an overview on significant genetic susceptibility factors for susceptibility and treatment outcome in chronic viral hepatitis C and B that have been identified by the classical candidate gene approach and genome wide studies and also highlights some recent findings on genetic factors for common adverse drug reactions (C) 2010 Elsevier Ltd All rights reserved